SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-213632
Filing Date
2021-07-13
Accepted
2021-07-13 08:18:01
Documents
13
Period of Report
2021-07-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d201559d8k.htm   iXBRL 8-K 25297
2 EX-99.1 d201559dex991.htm EX-99.1 8712
  Complete submission text file 0001193125-21-213632.txt   161260

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rxrx-20210713.xsd EX-101.SCH 2894
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxrx-20210713_lab.xml EX-101.LAB 18122
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxrx-20210713_pre.xml EX-101.PRE 11406
6 EXTRACTED XBRL INSTANCE DOCUMENT d201559d8k_htm.xml XML 3481
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 211086841
SIC: 2836 Biological Products, (No Diagnostic Substances)